Figure 1. Structure of resistance islands containing dfrA35 in IncC plasmids. (a) pEc158 resistance island and (b) ... Figure 1. Structure of resistance.

Slides:



Advertisements
Similar presentations
Figure 1 Annual number of isolates of imipenem-resistant P. aeruginosa
Advertisements

Figure 1. Ten chemotherapeutic drugs induce the bacterial SOS response
Figure 1. Direct evidence for the acquisition and demise of Tn6330 by DNA sequence alignment. (a) Comparison between ... Figure 1. Direct evidence for.
Figure 1. Comparative chromosome map of the CP-hvKP strain (NUHL30457) and 10 other hvKP strains (1158, CG43, HK787, ... Figure 1. Comparative chromosome.
Figure 1. Distribution of ABCB1 SNVs and haplotypes.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 Data-selection process
Figure 1 Flow diagram detailing the systematic review process.
Figure 1 Mechanism of mortality benefit associated with radial access
Figure 1. Colistin MIC distribution for the 153 colistin-resistant E
Figure 1. Variation in population size of the donor strain HN-1 and E
Figure 1. Linkage analyses of the SNPs in the MRE11 gene and haplotype blocks. Haplotype blocks were defined for all ... Figure 1. Linkage analyses of.
(A–B) Images of US ... (A–B) Images of US assessment of both patients who developed peripheral arthritis during vedolizumab treatment undergoing US-guided.
Figure 1. Structure of two poxtA-carrying plasmids in E
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1. Physician rankings from 0 to 100 in the odds of prescribing an antibiotic. The y-axis represents the null ... Figure 1. Physician rankings from.
Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.
AHA: American Heart Association; ALT: ...
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.
Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.
Fig. 1 CT demonstrating aortic wall thickening with renal artery involvement (short arrow). There is also subtle ... Fig. 1 CT demonstrating aortic wall.
Figure 1. SpeI-PFGE dendrogram comparing P
Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.
Fig. 1 MRI aspect of an osteitis of the left acetabulum at baseline (A), 3 months (B), 1 year (C) and 2 years later, ... Fig. 1 MRI aspect of an osteitis.
Figure 1. Uptake of relebactam into human OAT1, OAT3 and OCT2 stably transfected cells. Time-dependent uptake of ... Figure 1. Uptake of relebactam into.
Take home figure The protective role of CNP/NPR-B/NPRC.
Fig. 3 Interrelationship between themes describing the experiences of people with shoulder disorders Unless provided in the caption above, the following.
x-axis, post-partum days. Closed ...
Fig. 1 HRCT of the chest, showing centrilobular nodules (white arrows in A and B), a large subpleural nodule (black ... Fig. 1 HRCT of the chest, showing.
Fig. 1. A flowchart of cohort participants screened, enrolled and followed-up between 1 July 2015 and 31 May Fig. 1. A flowchart of cohort participants.
Fig. 1 Subacute cutaneous lupus erythematous at the lower limbs
Fig. 1 Flow chart of included patients for analyses
Fig. 1 Flow chart for selection of study subjects
Figure 1. Mean concentration–time profiles of ascending doses of ivermectin in (a) PSAC and (b) SAC. Weight-dependent ... Figure 1. Mean concentration–time.
Figure 1. Susceptibility of all P
Figure 1. (a) Geographical representation of sample collection area
Prevalence and distribution of ...
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1 Relationships between pair indices of dance performance (joint entropy or mutual information) and the past ... Figure 1 Relationships between.
Figure 1. Flow diagram for selection of articles for systematic review. Unless provided in the caption above, the following copyright applies to the content.
Figure 1. Sequence comparison of plasmid pG38 (GenBank accession no
Figure 1 (a) Genetic backbone of pECPB39 (MG886287) and pKP13a (CP003996) plasmids. In pECPB39, the ΔproP-mcr-5.3-chrB ... Figure 1 (a) Genetic backbone.
Figure 1. Time–kill studies for selected isolates (each line represents the average of duplicate studies). AMP, ... Figure 1. Time–kill studies for selected.
Figure 1 Immunohistochemistry for human cell differentiation molecules in samples of the right ventricular septum from ... Figure 1 Immunohistochemistry.
Figure 1. Percentage of Pacific and European children completing all components of B4SC in 2013 and 2015 Figure 1. Percentage of Pacific and European.
Figure 1 MIC test strips showing reversion of daptomycin resistance of isolate 5 passaged in vitro. This figure ... Figure 1 MIC test strips showing reversion.
(A) Hypoechoic ‘halo sign’ of ...
Figure 1. Outer membrane protein profiling of parental strain KJΔDEFΔ5 and its derivative fluoroquinolone-resistant ... Figure 1. Outer membrane protein.
Figure 1. Trunk and leg fat over study period. LS, log transformed.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1. Ability of fluconazole to improve survival of G
Fig. 1 Kaplan-Meier plot presenting no difference in progression to RA in patients with clinically suspect ... Fig. 1 Kaplan-Meier plot presenting no difference.
Figure 1. Colony morphology of an A. fumigatus non-WT strain and an A
Figure 1. The unique structures of the SCCmec type II element identified in ORSL strain CGMH-SL Figure 1. The unique structures of the SCCmec type.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1. Observed mean (SD) micafungin plasma concentrations.
Figure 1. Time–kill curves of M. abscessus CIP
Fig. 1 A network representation of top 100 co-occurring terms
Figure 1. Genetic context of blaNDM-21 on pNDM21_020023
Fig. 1 Statistics of the main characters’ dialogues.
Figure 1 Grant agencies and charitable foundations supporting Plan S.
Fig. 1 Schematic subcategorization of AAV in three clinically relevant disease categories defined by clinical ... Fig. 1 Schematic subcategorization of.
Figure 1. Percentage of samples with MDR (a), phenotypic ESBL-producing (b), fluoroquinolone-resistant (c) and ... Figure 1. Percentage of samples with.
Figure 1. CCG and practice decile and extreme percentile (1–9, 91–99) time trends, 2011–17. This figure appears in ... Figure 1. CCG and practice decile.
Figure 1 ABCDE of primary prevention.2
Figure 1. Forest plot of lung cancer mortality in LDCT trials.
Table 2. Mean noise level results for hand dryers in dBA
Figure 1. Kaplan–Meier curves showing the impact of the different pretreatment HIV-1 drug resistance categories on the ... Figure 1. Kaplan–Meier curves.
Presentation transcript:

Figure 1. Structure of resistance islands containing dfrA35 in IncC plasmids. (a) pEc158 resistance island and (b) ... Figure 1. Structure of resistance islands containing dfrA35 in IncC plasmids. (a) pEc158 resistance island and (b) INF164 resistance island, representing the four IncC plasmids from 2013. The thick central lines represent the island, and the flanking plasmid backbone sequence is represented by the nucleotide sequence of the adjacent 5 bp at either end. Arrows indicate the extent and orientation of genes and ORFs with the names indicated below. Resistance genes are shown in red and mer genes are purple. IS are shown as green or light blue boxes with an arrow representing the transposase gene inside, and other transposition genes are dark blue. CR1 is orange with a bar representing the ori end. Gene cassettes in the integron are narrow open boxes with a bar representing the attC site and an open bar represents the attI site. The intI1 gene is light green. Vertical bars indicate inverted repeats (IR) with a label above/below and the IS4321-like elements are shown above the 38 bp IR they interrupt. A black line above the central line identifies the source of segments of the resistance island. A red bar below represents the region cloned from pEc158. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) J Antimicrob Chemother, dkz148, https://doi.org/10.1093/jac/dkz148 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 2. Maximum likelihood tree of DfrA amino acid sequences, generated using MEGA (version 7.0.26). Branch numbering ... Figure 2. Maximum likelihood tree of DfrA amino acid sequences, generated using MEGA (version 7.0.26). Branch numbering represents percentage bootstrap support resampled 1000 times. The scale refers to the number of substitutions per site. DfrA35 is indicated in bold. GenBank accession numbers for the DNA sequences from which amino acid sequences were obtained are located next to the protein name. The proteins used are the same as those that could be obtained from accessions in ResFinder (accessed 24 November 2018), except for the following. The DfrA19 sequence has been used for both DfrA18 and DfrA19 in ResFinder and the correct accession for dfrA18 is AY034138. DfrA3b (AY162283), which is no longer available in ResFinder, is renamed DfrA11. DfrA13 (Z50802) has not been included as it is DfrA21 with a change to the sequence of a short segment of the protein caused by two frameshift mutations. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) J Antimicrob Chemother, dkz148, https://doi.org/10.1093/jac/dkz148 The content of this slide may be subject to copyright: please see the slide notes for details.